Amicus Therapeutics, Inc.
FOLD
Revenue
126.67M
▲16.27M▲14.73%
3 Months ChangeAssets
749.48M
▲27.70M▲3.84%
3 Months ChangeLiabilities
616.96M
▲25.87M▲4.38%
3 Months ChangeFree Cash Flow
-31.51M
▼-11.50M▼-57.44%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-17
Form 8-K
ID: 0001104659-24-109368
2024-08-08
Form 10-Q
ID: 0001178879-24-000009
2024-08-08
Form 8-K
ID: 0001104659-24-086987
2024-06-07
Form 8-K
ID: 0001104659-24-069634
2024-05-09
Form 10-Q
ID: 0001178879-24-000006
2024-05-09
Form 8-K
ID: 0001104659-24-059089
2024-02-28
Form 8-K
ID: 0001104659-24-028461
2024-01-08
Form 8-K
ID: 0001104659-24-002057
2023-12-05
Form 8-K
ID: 0001104659-23-123402
2023-11-08
Form 10-Q
ID: 0001178879-23-000016